--- title: "IDN, Integrated Delivery Network | MedTech Terms" description: "Network of healthcare facilities under common ownership or affiliation. Plain-English Commercialization definition for MedTech teams, with examples and related" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/idn#term", "name": "Integrated Delivery Network", "alternateName": "IDN", "description": "IDNs (HCA, CommonSpirit, Ascension, Kaiser Permanente, Sutter, Intermountain) span multiple hospitals, ambulatory sites, and post-acute facilities under common ownership. They centralize purchasing, formularies, and clinical pathways.", "url": "https://medtechterms.com/terms/idn", "termCode": "idn", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/idn#article", "headline": "IDN, Integrated Delivery Network", "description": "Network of healthcare facilities under common ownership or affiliation.", "url": "https://medtechterms.com/terms/idn", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/idn" }, "about": { "@id": "https://medtechterms.com/terms/idn#term" }, "articleSection": "Commercialization", "inLanguage": "en", "keywords": "Integrated Delivery Network, IDN, Commercialization, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "AHA IDN data", "url": "https://www.aha.org/", "publisher": { "@type": "Organization", "name": "AHA" } }, { "@type": "CreativeWork", "name": "AHRMM - Healthcare Supply Chain", "url": "https://www.ahrmm.org/", "publisher": { "@type": "Organization", "name": "AHRMM" } }, { "@type": "CreativeWork", "name": "AdvaMed Code of Ethics", "url": "https://www.advamed.org/our-work/code-of-ethics/", "publisher": { "@type": "Organization", "name": "AdvaMed" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/gpo#term", "name": "Group Purchasing Organization", "alternateName": "GPO", "url": "https://medtechterms.com/terms/gpo" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/vac#term", "name": "Value Analysis Committee", "alternateName": "VAC", "url": "https://medtechterms.com/terms/vac" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Commercialization", "item": "https://medtechterms.com/terms?cat=Commercialization" }, { "@type": "ListItem", "position": 4, "name": "Integrated Delivery Network", "item": "https://medtechterms.com/terms/idn" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/idn#faq", "mainEntity": [ { "@type": "Question", "name": "How do IDNs impact MedTech market access?", "acceptedAnswer": { "@type": "Answer", "text": "IDNs centralize purchasing and clinical pathways, meaning that gaining approval at the corporate level can significantly open market access across numerous facilities. Conversely, failing to secure an IDN contract can limit access to a large segment of the healthcare market." } }, { "@type": "Question", "name": "What cybersecurity considerations are relevant when working with IDNs?", "acceptedAnswer": { "@type": "Answer", "text": "MedTech companies must ensure their devices and accompanying software meet the IDN's stringent cybersecurity requirements, often involving adherence to standards like NIST Cybersecurity Framework or ISO 27001, to protect patient data and network integrity. This includes robust vulnerability management and secure data exchange protocols." } }, { "@type": "Question", "name": "Do IDNs influence regulatory submissions for MedTech products?", "acceptedAnswer": { "@type": "Answer", "text": "IDNs do not directly influence regulatory submissions to bodies like the FDA or notified bodies. However, their internal policies and technology integration requirements may necessitate specific device features, data outputs, or cybersecurity measures that indirectly affect a device's design and subsequently, its regulatory compliance documentation specified in standards such as IEC 62304 for software or IEC 60601 for electrical safety." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Commercialization](/terms?cat=Commercialization) 6. / 7. Integrated Delivery Network [All terms](/terms) Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)IDN # Integrated Delivery Network Network of healthcare facilities under common ownership or affiliation. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition IDNs (HCA, CommonSpirit, Ascension, Kaiser Permanente, Sutter, Intermountain) span multiple hospitals, ambulatory sites, and post-acute facilities under common ownership. They centralize purchasing, formularies, and clinical pathways. What the regulation says While specific regulations do not directly govern Integrated Delivery Networks (IDNs) as entities, their constituent facilities and services must comply with applicable MedTech regulations, such as those enforced by the FDA in the United States and the EU [MDR](/terms/mdr-reporting) in Europe, covering medical devices used within their networks. The operation of IDNs also implicates considerations for patient safety and quality management systems as outlined in standards like ISO 9001 and [ISO 13485](/terms/iso-13485) when applicable to their activities involving medical devices. Furthermore, data privacy and security within IDNs are subject to regulations like [HIPAA](/terms/hipaa) in the US and GDPR in the EU, given their extensive handling of patient health information. ## What this means in practice Selling into IDNs typically requires corporate-level value-analysis approval before site-level adoption. Contract wins at large IDNs can swing quarterly results materially. ## Examples - A MedTech company developing a new imaging device must navigate the corporate value analysis committee of a large IDN to get its product approved for purchase across the IDN's 50 hospitals. The IDN mandates that all medical devices integrate with its existing electronic health record system, requiring the MedTech company to demonstrate compliance with interoperability standards like HL7. An IDN implements a new cybersecurity policy requiring all connected medical devices to undergo a penetration test and risk assessment prior to procurement, adding a specific requirement for MedTech manufacturers beyond typical regulatory clearance. After a successful pilot at two facilities, a surgical robotics company works with an IDN to standardize surgical protocols and training across its network, ensuring consistent adoption and utilization of the device. A MedTech manufacturer providing disposable supplies must respond to an IDN's request for proposal that specifies unique packaging, inventory management interfaces, and delivery logistics tailored to the IDN's centralized supply chain operations. A cardiac device manufacturer collaborates with an IDN to integrate device data into the IDN's population health management platform, requiring secure APIs and adherence to data privacy regulations like HIPAA. - An IDN Common pitfalls - • A common pitfall is underestimating the complexity of an IDN's internal approval processes, which often involves multiple stakeholders beyond clinical users. - • Companies often fail to recognize that IDN contracts may require specialized cybersecurity and data integration agreements distinct from standard device sales. - • Another mistake is neglecting the impact of an IDN's centralized formulary or preferred product lists on device adoption and market access. - • Ignoring the IDN's own quality management and risk management frameworks can lead to friction in product implementation and support. - • Many MedTech companies mistakenly believe that a single site-level approval within an IDN translates to network-wide adoption without further strategic engagement. ## Frequently asked questions How do IDNs impact MedTech market access? IDNs centralize purchasing and clinical pathways, meaning that gaining approval at the corporate level can significantly open market access across numerous facilities. Conversely, failing to secure an IDN contract can limit access to a large segment of the healthcare market. What cybersecurity considerations are relevant when working with IDNs? Do IDNs influence regulatory submissions for MedTech products? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Commercialization Group Purchasing Organization(GPO) Entity that aggregates hospital purchasing to negotiate prices with suppliers. ](/terms/gpo)[ Commercialization Value Analysis Committee(VAC) Hospital cross-functional committee that reviews and approves new product purchases. ](/terms/vac) ### More in Commercialization · Same category [ Commercialization AdvaMed Code of Ethics Industry code governing interactions between U.S. medical-device companies and healthcare professionals. ](/terms/advamed-code)[ Commercialization Advisory Board Convening of external experts to advise on strategy or product. ](/terms/advisory-board)[ Commercialization Anti-Kickback Statute(AKS) U.S. criminal statute prohibiting remuneration to induce federal healthcare business. ](/terms/anti-kickback)[ Commercialization Bottom-Up Market Sizing Building market size from procedure volumes × price × penetration. ](/terms/bottom-up-sizing) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 AHA· 1 AHRMM· 1 AdvaMed· 1 1. [1 AHA IDN data Verified AHA · aha.org ](https://www.aha.org/) 2. [2 AHRMM - Healthcare Supply Chain Verified AHRMM · ahrmm.org ](https://www.ahrmm.org/) 3. [3 AdvaMed Code of Ethics Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/code-of-ethics/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Selling a connected device into health systems? Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Commercialization Acronym IDN Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=idn) Learn in 60 seconds Card Lesson Quiz Network of healthcare facilities under common ownership or affiliation. - · Selling into IDNs typically requires corporate-level value-analysis approval before site-level adoption. - · Contract wins at large IDNs can swing quarterly results materially. - · They centralize purchasing, formularies, and clinical pathways. Remember this Watch out: A common pitfall is underestimating the complexity of an IDN's internal approval processes, which often involves multiple stakeholders beyond clinical users. Related terms - [Group Purchasing Organization(GPO) ](/terms/gpo) - [Value Analysis Committee(VAC) ](/terms/vac) You may also need Auto-suggested from Commercialization and shared keywords. - [Medhacking ](/terms/medhacking) - [Decentralized Clinical Trial(DCT) ](/terms/decentralized-clinical-trial) - [Ambulatory Payment Classification(APC) ](/terms/apc) - [Clinical Decision Support(CDS) ](/terms/cds) - [Common Specifications(CS) ](/terms/common-specifications) - [Common Specifications (IVDR)(CS) ](/terms/ivdr-common-specifications) [All Commercialization terms](/terms?cat=Commercialization) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)